Seroconversion of hepatitis B during chemotherapy for malignant lymphoma

Yona Kitay-Cohen, Avishay Elis, Arie Lalkin, Michael Lishner*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


We report a patient with chronic hepatitis B infection who developed lymphoma and was treated with concomitant cytotoxic and antiviral therapy. In contrast to the expected life threatening fulminant hepatitis that is often reported in this clinical setting, in our patient normalization of liver function tests with temporary loss of viral replication markers were seen. The implications of this rare clinical and serological course are discussed.

Original languageEnglish
Pages (from-to)199-202
Number of pages4
JournalLeukemia and Lymphoma
Issue number1-2
StatePublished - 1999


  • Hepatitis B
  • Interferon
  • Lymphoma


Dive into the research topics of 'Seroconversion of hepatitis B during chemotherapy for malignant lymphoma'. Together they form a unique fingerprint.

Cite this